Company Statements
Filter By Year
February 15, 2024
Gilead Statement on Magrolimab Studies in Solid Tumors
February 7, 2024
Gilead Statement on Discontinuation of Phase 3 ENHANCE-3 Study in AML
Filter By Year
Some of the content on this page is not intended for users outside